All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
TNGX / Tango Therapeutics, Inc.
|
|
|
|
|
|
|
|
RCKTW / Rocket Pharmaceuticals, Inc. - Equity Warrant
|
|
|
|
|
|
|
|
LENZ / LENZ Therapeutics, Inc.
|
|
|
|
|
|
|
|
EPIX / ESSA Pharma Inc.
|
|
|
|
|
|
|
|
APYX / Apyx Medical Corporation
|
|
|
|
|
|
|
|
ARVN / Arvinas, Inc.
|
|
|
|
|
|
|
|
PTGX / Protagonist Therapeutics, Inc.
|
|
|
|
|
|
|
|
DNTH / Dianthus Therapeutics, Inc.
|
|
|
|
|
|
|
|
MRTX / Mirati Therapeutics, Inc.
|
|
|
|
|
|
|
|
KYTX / Kyverna Therapeutics, Inc.
|
|
|
|
|
|
|
|
NGNE / Neurogene Inc.
|
|
|
|
|
|
|
|
GKOS / Glaukos Corporation
|
|
|
|
|
|
|
|
MDGL / Madrigal Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
SABS / SAB Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
SGHT / Sight Sciences, Inc.
|
|
|
|
|
|
|
|
SWTX / SpringWorks Therapeutics, Inc.
|
|
|
|
|
|
|
|
DHR / Danaher Corporation
|
|
|
|
|
|
|
|
GH / Guardant Health, Inc.
|
|
|
|
|
|
|
|
SIENQ / Sientra, Inc.
|
|
|
|
|
|
|
|
CLDX / Celldex Therapeutics, Inc.
|
|
|
|
|
|
|
|
BRKR / Bruker Corporation
|
|
|
|
|
|
|
|
LRMR / Larimar Therapeutics, Inc.
|
|
|
|
|
|
|
|
RDNT / RadNet, Inc.
|
|
|
|
|
|
|
|
EXAS / Exact Sciences Corporation
|
|
|
|
|
|
|
|
AKRO / Akero Therapeutics, Inc.
|
|
|
|
|
|
|
|
VCEL / Vericel Corporation
|
|
|
|
|
|
|
|
VRDN / Viridian Therapeutics, Inc.
|
|
|
|
|
|
|
|
JANX / Janux Therapeutics, Inc.
|
|
|
|
|
|
|
|
FULC / Fulcrum Therapeutics, Inc.
|
|
|
|
|
|
|
|
SAGE / Sage Therapeutics, Inc.
|
|
|
|
|
|
|
|
TXG / 10x Genomics, Inc.
|
|
|
|
|
|
|
|
AVADEL PHARMACEUTICALS PLC
/ SPONSORED ADR (05337M104) |
|
|
|
|
|
|
|
SWAV / Shockwave Medical, Inc.
|
|
|
|
|
|
|
|
TMO / Thermo Fisher Scientific Inc.
|
|
|
|
|
|
|
|
ISRG / Intuitive Surgical, Inc.
|
|
|
|
|
|
|
|
ARGX / argenx SE - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
ROIV / Roivant Sciences Ltd.
|
|
|
|
|
|
|
|
TRML / Tourmaline Bio, Inc.
|
|
|
|
|
|
|
|
DYN / Dyne Therapeutics, Inc.
|
|
|
|
|
|
|
|
CUTRQ / Cutera, Inc.
|
|
|
|
|
|
|
|
ALNY / Alnylam Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
APGE / Apogee Therapeutics, Inc.
|
|
|
|
|
|
|
|
SYK / Stryker Corporation
|
|
|
|
|
|
|
|
AXSM / Axsome Therapeutics, Inc.
|
|
|
|
|
|
|
|
ALKS / Alkermes plc
|
|
|
|
|
|
|
|
STOK / Stoke Therapeutics, Inc.
|
|
|
|
|
|
|
|
IMTX / Immatics N.V.
|
|
|
|
|
|
|
|
XGN / Exagen Inc.
|
|
|
|
|
|
|
|
MIST / Milestone Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
TARS / Tarsus Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
CRGX / CARGO Therapeutics, Inc.
|
|
|
|
|
|
|
|
SABS / SAB Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
GHRS / GH Research PLC
|
|
|
|
|
|
|
|
OBIO / Orchestra BioMed Holdings, Inc.
|
|
|
|
|
|
|
|
CYTK / Cytokinetics, Incorporated
|
|
|
|
|
|
|
|
ETNB / 89bio, Inc.
|
|
|
|
|
|
|
|
PEN / Penumbra, Inc.
|
|
|
|
|
|
|
|
TSHA / Taysha Gene Therapies, Inc.
|
|
|
|
|
|
|
|
MRUS / Merus N.V.
|
|
|
|
|
|
|
|
IMUX / Immunic, Inc.
|
|
|
|
|
|
|
|
ESTA / Establishment Labs Holdings Inc.
|
|
|
|
|
|
|
|
XAIR / Beyond Air, Inc.
|
|
|
|
|
|
|
|
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
SGMT / Sagimet Biosciences Inc.
|
|
|
|
|
|
|
|
PTCT / PTC Therapeutics, Inc.
|
|
|
|
|
|
|
|
INSM / Insmed Incorporated
|
|
|
|
|
|
|
|
ALUR / Allurion Technologies Inc.
|
|
|
|
|
|
|
|
CGON / CG Oncology, Inc.
|
|
|
|
|
|
|
|
RCKT / Rocket Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
SLRN / Acelyrin, Inc.
|
|
|
|
|
|
|
|
SYRE / Spyre Therapeutics, Inc.
|
|
|
|
|
|
|
|
URGN / UroGen Pharma Ltd.
|
|
|
|
|
|
|
|
ACAD / ACADIA Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
RGNX / REGENXBIO Inc.
|
|
|
|
|
|
|
|
RARE / Ultragenyx Pharmaceutical Inc.
|
|
|
|
|
|
|
|
ARYD / ARYA Sciences Acquisition Corp IV
|
|
|
|
|
|
|
|
MASI / Masimo Corporation
|
|
|
|
|
|
|
|
NTRA / Natera, Inc.
|
|
|
|
|
|
|
|
ACET / Adicet Bio, Inc.
|
|
|
|
|
|
|
|
RNA / Avidity Biosciences, Inc.
|
|
|
|
|
|
|
|